Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000879461 | SCV001022495 | likely benign | not provided | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Molecular Oncology Research Center, |
RCV001374488 | SCV001438640 | uncertain significance | Hereditary breast ovarian cancer syndrome | 2020-08-01 | criteria provided, single submitter | research | |
Mendelics | RCV003492183 | SCV002517047 | likely benign | Hereditary cancer | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000879461 | SCV001806849 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000879461 | SCV001973399 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003908387 | SCV004722818 | likely benign | FAN1-related disorder | 2022-02-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |